Élise Dumas

664 total citations · 1 hit paper
25 papers, 195 citations indexed

About

Élise Dumas is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Élise Dumas has authored 25 papers receiving a total of 195 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 6 papers in Cancer Research and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Élise Dumas's work include Cancer Risks and Factors (8 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Breast Cancer Treatment Studies (6 papers). Élise Dumas is often cited by papers focused on Cancer Risks and Factors (8 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Breast Cancer Treatment Studies (6 papers). Élise Dumas collaborates with scholars based in France, Switzerland and India. Élise Dumas's co-authors include Anne‐Sophie Hamy, Fabien Reyal, Enora Laas, Paul Gougis, Floriane Jochum, Judicaël Hotton, Baptiste Abbar, Jean‐Philippe Spano, Joe‐Elie Salem and Kévin Bihan and has published in prestigious journals such as Journal of Clinical Oncology, American Journal of Obstetrics and Gynecology and British journal of surgery.

In The Last Decade

Élise Dumas

20 papers receiving 189 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clinical spectrum and evolution of immune-checkpoint inhibitors toxicities over a decade—a worldwide perspective

2024 67 citations Paul Gougis, Floriane Jochum et al. EClinicalMedicine profile →

Peers

Élise Dumas

ONCOL

PRM

IMMUN

PHEOH

Carlos Bonilla Colombia

Tobias Engler Germany

Anne Jacobsen Germany

Laura Rodríguez Spain

Rita Leporati Italy

Ahwon Jeong Canada

Jasmine C. Huynh United States

Amy Woodruff United States

Mary Kay Barton Canada

Yasir Khan United States

Carlos Bonilla Colombia

Élise Dumas

78 ×0.6

ONCOL

48 ×1.3

PRM

18 ×0.6

IMMUN

20 ×0.8

11 ×0.6

PHEOH

Citations per year, relative to Élise Dumas Élise Dumas (= 1×) peers Carlos Bonilla

Countries citing papers authored by Élise Dumas

Since Specialization

Citations

This map shows the geographic impact of Élise Dumas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Élise Dumas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Élise Dumas more than expected).

Fields of papers citing papers by Élise Dumas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Élise Dumas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Élise Dumas. The network helps show where Élise Dumas may publish in the future.

Co-authorship network of co-authors of Élise Dumas

This figure shows the co-authorship network connecting the top 25 collaborators of Élise Dumas. A scholar is included among the top collaborators of Élise Dumas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Élise Dumas. Élise Dumas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Laas, Enora, Thomas Gaillard, Benoît Couturaud, et al.. (2025). The Impact of Fat Graft Reconstructive Surgery on Prognosis in Young Women with Breast Cancer: A Study from the French Insurance Databases. Plastic & Reconstructive Surgery. 156(5). 691–701.

Laurent, L. J. M., Baptiste Abbar, Kévin Bihan, et al.. (2025). Comedications Associated with Immune‐Related Adverse Events from Immune‐Checkpoint Inhibitors. Clinical Pharmacology & Therapeutics. 118(3). 593–599. 4 indexed citations

Dumas, Élise, Floriane Jochum, Florence Coussy, et al.. (2025). Explaining the Relationships Between Age, Endocrine Therapy Persistence, and Risk of Recurrence in Hormone Receptor–Positive Early Breast Cancer: A Nationwide Cohort Study. Journal of Clinical Oncology. 43(16). 1863–1874. 1 indexed citations

Dumas, Élise & Mats Julius Stensrud. (2025). How hazard ratios can mislead and why it matters in practice. European Journal of Epidemiology. 40(6). 603–609. 1 indexed citations

Cabannes‐Hamy, Aurélie, Floriane Jochum, Kévin Bihan, et al.. (2025). BCR::ABL1 Tyrosine Kinase Inhibitors During Pregnancy, a Disproportionality Analysis of Vigibase. Clinical Pharmacology & Therapeutics. 118(3). 705–714.

Jochum, Floriane, Anne‐Sophie Hamy, Paul Gougis, et al.. (2025). A reproducible framework for monitoring the impact of randomized clinical trials on clinical practice using large-scale real-world data: application to gynaecological surgical trials using the French national healthcare database. EClinicalMedicine. 80. 103053–103053.

Gougis, Paul, Floriane Jochum, Baptiste Abbar, et al.. (2024). Clinical spectrum and evolution of immune-checkpoint inhibitors toxicities over a decade—a worldwide perspective. EClinicalMedicine. 70. 102536–102536. 67 indexed citations breakdown →

Jochum, Floriane, Anne‐Sophie Hamy, Paul Gougis, et al.. (2024). Sex-related differences in oncological surgery and postoperative outcomes: comprehensive, nationwide study in France. British journal of surgery. 111(8). 2 indexed citations

Assaad, Souad, Lidia Delrieu, Bertrand Favier, et al.. (2024). Early morning immune checkpoint blockade and overall survival of patients with metastatic cancer: An In-depth chronotherapeutic study. European Journal of Cancer. 199. 113571–113571. 16 indexed citations

10.

Jochum, Floriane, Élise Dumas, Paul Gougis, et al.. (2024). Survival outcomes of primary vs interval cytoreductive surgery for International Federation of Gynecology and Obstetrics stage IV ovarian cancer: a nationwide population-based target trial emulation. American Journal of Obstetrics and Gynecology. 232(2). 194.e1–194.e11. 4 indexed citations

11.

Gougis, Paul, Anne‐Sophie Hamy, Floriane Jochum, et al.. (2024). Immune Checkpoint Inhibitor Use During Pregnancy and Outcomes in Pregnant Individuals and Newborns. JAMA Network Open. 7(4). e245625–e245625. 21 indexed citations

12.

Gougis, Paul, et al.. (2024). Radiotherapy for oligoprogressive disease in non-small cell lung cancer treated with pembrolizumab in first-line setting: a retrospective study. Translational Lung Cancer Research. 13(12). 3603–3615.

13.

Jochum, Floriane, Anne‐Sophie Hamy, Paul Gougis, et al.. (2023). Effects of gender and socio-environmental factors on health-care access in oncology: a comprehensive, nationwide study in France. EClinicalMedicine. 65. 102298–102298. 4 indexed citations

14.

Gougis, Paul, Floriane Jochum, Kévin Bihan, et al.. (2023). Treatments During Pregnancy Targeting ERBB2 and Outcomes of Pregnant Individuals and Newborns. JAMA Network Open. 6(10). e2339934–e2339934. 8 indexed citations

15.

Dumas, Élise, Florence Coussy, Enora Laas, et al.. (2022). The French Early Breast Cancer Cohort (FRESH): A Resource for Breast Cancer Research and Evaluations of Oncology Practices Based on the French National Healthcare System Database (SNDS). Cancers. 14(11). 2671–2671. 14 indexed citations

16.

Dumas, Élise, et al.. (2022). Évolution des pratiques contraceptives en France : un état des lieux de 2014 à 2019. Gynécologie Obstétrique Fertilité & Sénologie . 50(7-8). 535–541.

17.

Delrieu, Lidia, Anne‐Sophie Hamy, Florence Coussy, et al.. (2022). Digital phenotyping in young breast cancer patients treated with neoadjuvant chemotherapy (the NeoFit Trial): protocol for a national, multicenter single-arm trial. BMC Cancer. 22(1). 493–493. 3 indexed citations

18.

Laas, Enora, Élise Dumas, Jean‐Yves Pierga, et al.. (2021). The Prognostic Value of Lymph Node Involvement after Neoadjuvant Chemotherapy Is Different among Breast Cancer Subtypes. Cancers. 13(2). 171–171. 6 indexed citations

19.

Labrosse, Julie, Enora Laas, Florence Coussy, et al.. (2021). Time to Pregnancy, Obstetrical and Neonatal Outcomes after Breast Cancer: A Study from the Maternity Network for Young Breast Cancer Patients. Cancers. 13(5). 1070–1070. 5 indexed citations

20.

Delrieu, Lidia, Liacine Bouaoun, Douae El Fatouhi, et al.. (2021). Patterns of Sequelae in Women with a History of Localized Breast Cancer: Results from the French VICAN Survey. Cancers. 13(5). 1161–1161. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact